Laila C. Roisman
Ashdod, D, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Advances in Lung Cancer Basic and Translational Research in 2025 - Overview and Perspectives Focusing on NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 24, 2025
Lurbinectedin for extensive stage - small cell lung cancer (ES-SCLC): real world response patterns and survival outcomes.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 24, 2025
The PESGA Trial: A Prospective, Open-Label, Single-Arm, Phase II Study to Evaluate First Line Therapy for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Patients, Treated by Induction Carboplatin/Etoposide/Pembrolizumab Followed by Maintenance of Pembrolizumab/ Sacituzumab Govitecan.
Journal: Clinical lung cancer
Published: December 20, 2024
Characterization of the xeno-GVHD response generated by advanced lung cancer patient peripheral blood mononuclear cells in NSG-SGM3 mice.
Journal: Translational lung cancer research
Published: September 01, 2024
Amivantamab as a salvage therapy post-EGFR-tyrosine kinase inhibitor failure in patients with mutated EGFR non-small cell lung cancer.
Journal: Translational lung cancer research
Published: July 16, 2024
Case report: The efficacy of adding high doses of intravenous vitamin C to the combination therapy of atezolizumab and bevacizumab in unresectable HCC.
Journal: Frontiers in medicine
Published: July 07, 2024
Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: January 20, 2024
The interaction of mast cells with membranes from lung cancer cells induces the release of extracellular vesicles with a unique miRNA signature.
Journal: Scientific reports
Published: August 31, 2023
Case report: The effect of induction targeted therapies in stage III driver mutants non-small cell lung cancer.
Journal: Frontiers in oncology
Published: August 30, 2023
Radiological artificial intelligence - predicting personalized immunotherapy outcomes in lung cancer.
Journal: NPJ precision oncology
Published: July 17, 2023
Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib.
Journal: Frontiers in oncology
Published: December 15, 2022
Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 Study.
Journal: International journal of radiation oncology, biology, physics
Published: November 14, 2022
Last Updated: 09/26/2026